LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Aurinia Pharmaceuticals Inc.

Similar companies to Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. Tech Stack

Aurinia Pharmaceuticals Inc. uses 8 technology products and services including Power BI, Optanon, ADP TotalSource, and more. Explore Aurinia Pharmaceuticals Inc.'s tech stack below.

  • Power BI
    Business Intelligence
  • Optanon
    Consent Management
  • ADP TotalSource
    Human Resource
  • Amazon Web Services
    Platform As A Service
  • Clarizen
    Project Management
  • Buildout
    Real Estate Marketing
  • Apache HTTP Server
    Web Servers
  • QuoteMedia
    Widgets

Media & News

Aurinia Pharmaceuticals Inc.'s Email Address Formats

Aurinia Pharmaceuticals Inc. uses at least 1 format(s):
Aurinia Pharmaceuticals Inc. Email FormatsExamplePercentage
FLast@auriniapharma.comJDoe@auriniapharma.com
98%
FMiddleLast@auriniapharma.comJMichaelDoe@auriniapharma.com
1%
LF@auriniapharma.comDJ@auriniapharma.com
1%

Frequently Asked Questions

Where is Aurinia Pharmaceuticals Inc.'s headquarters located?

Minus sign iconPlus sign icon
Aurinia Pharmaceuticals Inc.'s main headquarters is located at Edmonton, Alberta CA. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Aurinia Pharmaceuticals Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Aurinia Pharmaceuticals Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aurinia Pharmaceuticals Inc.'s stock symbol?

Minus sign iconPlus sign icon
Aurinia Pharmaceuticals Inc. is a publicly traded company; the company's stock symbol is AUPH.

What is Aurinia Pharmaceuticals Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Aurinia Pharmaceuticals Inc.'s official website is auriniapharma.com and has social profiles on LinkedIn.

How much revenue does Aurinia Pharmaceuticals Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Aurinia Pharmaceuticals Inc.'s annual revenue reached $75M.

What is Aurinia Pharmaceuticals Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Aurinia Pharmaceuticals Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Aurinia Pharmaceuticals Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Aurinia Pharmaceuticals Inc. has approximately 258 employees across 3 continents, including North AmericaEuropeAsia. Key team members include CFO: D. B.Chief Information Officer: M. G.Chief Financial Officer: J. M.. Explore Aurinia Pharmaceuticals Inc.'s employee directory with LeadIQ.

What industry does Aurinia Pharmaceuticals Inc. belong to?

Minus sign iconPlus sign icon
Aurinia Pharmaceuticals Inc. operates in the Biotechnology Research industry.

What technology does Aurinia Pharmaceuticals Inc. use?

Minus sign iconPlus sign icon
Aurinia Pharmaceuticals Inc.'s tech stack includes Power BIOptanonADP TotalSourceAmazon Web ServicesClarizenBuildoutApache HTTP ServerQuoteMedia.

What is Aurinia Pharmaceuticals Inc.'s email format?

Minus sign iconPlus sign icon
Aurinia Pharmaceuticals Inc.'s email format typically follows the pattern of . Find more Aurinia Pharmaceuticals Inc. email formats with LeadIQ.

How much funding has Aurinia Pharmaceuticals Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, Aurinia Pharmaceuticals Inc. has raised $200M in funding. The last funding round occurred on Jul 22, 2020 for $200M.

When was Aurinia Pharmaceuticals Inc. founded?

Minus sign iconPlus sign icon
Aurinia Pharmaceuticals Inc. was founded in 2013.
Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc.

Biotechnology ResearchAlberta, Canada201-500 Employees

We pursue promising science to address some of the toughest challenges in autoimmune disease. 
 
Community guidelines:
1. By posting to our social media channels, or otherwise responding or commenting on our posts, you are agreeing to abide by these guidelines, which apply in addition to any terms and conditions or other notices or disclaimers that we may apply, or that may be applied by the host of the social media platform itself. 
 
2. Unless posts are from an official Aurinia social media handle, none of the posts or comments are posts made by us, but from members of the public. We take no responsibility for comments or posts made by third parties on our channels, and the content of those comments or posts (including any opinions or statements) may not reflect our views, and are the responsibility of the individual posting them.
 
3. We may discuss medical and health-related topics on our social media feeds. The content we post, and any associated content shared by other users, should not be taken as medical advice. We ask that you refrain from soliciting or posting medical advice on this feed. For advice and information related to your health, please seek advice from your doctor or other healthcare professional. 
 
4. Aurinia reserves the right to remove any content or comments that violate these guidelines or are otherwise deemed inappropriate. We may block or ban users who repeatedly violate these guidelines or engage in disruptive behavior.  
 
To learn more, visit: https://www.auriniapharma.com/aurinia-community-guidelines 
 
US-NA-2300266 08/23

Section iconCompany Overview

Headquarters
Edmonton, Alberta CA
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AUPH
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconFunding & Financials

  • $200M

    Aurinia Pharmaceuticals Inc. has raised a total of $200M of funding over 7 rounds. Their latest funding round was raised on Jul 22, 2020 in the amount of $200M.

  • $50M$100M

    Aurinia Pharmaceuticals Inc.'s revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $200M

    Aurinia Pharmaceuticals Inc. has raised a total of $200M of funding over 7 rounds. Their latest funding round was raised on Jul 22, 2020 in the amount of $200M.

  • $50M$100M

    Aurinia Pharmaceuticals Inc.'s revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.